Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SGPharma is a private Indian pharmaceutical company focused on the manufacturing and marketing of generic medicines and pharmaceutical formulations. The company appears to specialize in a broad portfolio of small-molecule finished dosage products, including injectables, tablets, capsules, oral suspensions, and other formulations across cardiovascular, anti-infective, and hospital-focused categories. Publicly visible product listings indicate a meaningful commercial portfolio rather than a development-stage biotech pipeline, with products such as adenosine injection, alprostadil injection, aztreonam for injection, bosentan tablets, pirfenidone tablets, and rivaroxaban tablets. SGPharma also highlights manufacturing, quality assurance, analytical method development, validation, impurity profiling, dissolution studies, formulation development, and export capabilities. Overall, the company is best characterized as an active, private, commercial-stage generic pharma manufacturer rather than an R&D-led biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SGPharma.